Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

December 31, 2003

Conditions
Kidney Cancer
Interventions
DRUG

bryostatin 1

Trial Locations (17)

15905

Conemaugh Memorial Hospital, Johnstown

16602

Bon Secours-Holy Family Health System, Altoona

19026

Delaware County Memorial Hospital, Drexel Hill

19047

Saint Mary Medical Center, Langhorne

19111

Fox Chase Cancer Center, Philadelphia

19446

North Penn Hospital, Lansdale

19464

Pottstown Memorial Regional Cancer Center, Pottstown

08822

Hunterdon Regional Cancer Center, Flemington

08701

Kimball Medical Center, Lakewood

08332

South Jersey Hospital - Millville, Millville

08060

Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County, Mount Holly

07701

Riverview Medical Center, Red Bank

08755

Community Medical Center, Toms River

08629

St. Francis Medical Center, Trenton

17105-8700

Pinnacle Health Hospitals, Harrisburg

19301-1792

Paoli Memorial Hospital, Paoli

19612-6052

Reading Hospital and Medical Center, Reading

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003968 - Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter